Table 2.
Author | Year | Country | Population | M/F | DTF | |||||
---|---|---|---|---|---|---|---|---|---|---|
Success | Failure | |||||||||
Mean | SD | N | Mean | SD | N | |||||
Abdelwahed et al. (13) | 2019 | Egypt | 65 | 40/25 | 49.48 | 12.5 | 51 | 27.83 | 9.95 | 14 |
Alam et al. (14) | 2022 | Bangladesh | 31 | 19/12 | 22.34 | 2.73 | 18 | 14.74 | 6.89 | 13 |
Elshazly et al. (15) | 2020 | Egypt | 62 | NR | 33.52 | 14.51 | 34 | 18.57 | 9.37 | 28 |
Eltrabili et al. (16) | 2019 | Egypt | 35 | 16/19 | 43.43 | 7.35 | 17 | 22.31 | 13.37 | 13 |
Farghaly et al. (17) | 2017 | Egypt | 54 | 31/23 | 60.49 | 35.60 | 40 | 47.43 | 51.64 | 14 |
Ferrari et al. (18) | 2014 | Italy | 46 | 34/12 | 52.43 | 20.27 | 29 | 26 | 6.46 | 17 |
Kaur et al. (20) | 2022 | India | 50 | NR | 36.57 | 8.22 | 31 | 19.26 | 3.49 | 19 |
Li et al. (21) | 2021 | China | 101 | 42/59 | 49.48 | 12.5 | 69 | 27.83 | 9.95 | 32 |
Lin et al. (22) | 2024 | China | 79 | 69/10 | 35 | 7.8 | 57 | 28.7 | 8.1 | 22 |
Osman et al. (23) | 2017 | Egypt | 68 | NR | 33.50 | 1.56 | 50 | 23.11 | 4.11 | 18 |
Sabetian et al. (25) | 2024 | Iran | 50 | 39/11 | 51.99 | 21.33 | 26 | 48.33 | 11.55 | 24 |
Theerawit et al. (10) | 2018 | Thailand | 52 | 38/14 | 37 | 14 | 51 | 28 | 13 | 11 |
Yoo et al. (26) | 2018 | Korea | 60 | 42/18 | 40.40 | 28.44 | 47 | 24.06 | 25.49 | 13 |